Pharmaceutical composition for treating xerophthalmia

Abstract

The invention relates to a pharmaceutical composition for treating xerophthalmia. The pharmaceutical composition is a medicament prepared from the following components in parts by weight: 1-10 parts of zornia diphylla pers, 2-10 parts of populuspseud-simoni, 5-20 parts of evergreen mucuna root and leaf, 5-25 parts of pentapetes phoenicea, 1-10 parts of hupeh bauhinia root, 10-30 parts of impatiens aquatillis hook, 1-10 parts of streptocaulon griffithii hook, 1-10 parts of ruellia neesiana and 5-15 parts of spreading violet. The pharmaceutical composition for treating xerophthalmia disclosed by the invention is prepared from natural crude drugs, is simple and available in components, and significant in curative effect, and can be used for effectively treating the xerophthalmia. Therefore, the pharmaceutical composition is very applicable to clinical popularization.

Description

technical field [0001] The invention relates to the field of medicine, in particular, the invention relates to a pharmaceutical composition for treating dry eye. Background technique [0002] Dry eye is one of the most common diseases in ophthalmology. With the development of modern technology, the number of patients with dry eye is also increasing rapidly. It is a group of ocular surface diseases with complex etiology and various clinical manifestations. Reduced and a series of eye discomfort. Such as: fatigue, dryness, burning, foreign body sensation and other symptoms. The current treatment is mainly to use artificial tears, etc., and the application of traditional Chinese medicine is also on the rise day by day, and there are many treatments. However, the search for more rational drugs never stops. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating dry eye. [0004] In order to achieve the...

AI Technical Summary

Problems solved by technology

But the search for more r

Images